Toronto - Delayed Quote CAD

Microbix Biosystems Inc. (MBX.TO)

0.3250 -0.0100 (-2.99%)
At close: April 26 at 3:59 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
22,420.5880
16,514.7760
19,076.2410
18,592.9600
10,524.9040
Cost of Revenue
9,902.8980
9,033.4420
7,951.3990
7,549.0200
5,864.0070
Gross Profit
12,517.6900
7,481.3340
11,124.8420
11,043.9400
4,660.8970
Operating Expense
11,482.0740
10,217.7660
8,514.6290
6,207.3450
5,185.4980
Operating Income
1,035.6160
-2,736.4320
2,610.2130
4,836.5950
-524.6010
Net Non Operating Interest Income Expense
-399.0420
-381.6360
-744.2900
-1,603.2050
-1,056.1020
Other Income Expense
--
3,078.5850
--
--
-3,078.5850
Pretax Income
3,715.1590
-39.4830
1,865.9230
3,233.3900
-4,659.2880
Tax Provision
--
--
77.2340
--
1,568.2370
Net Income Common Stockholders
3,715.1580
-39.4830
1,788.6890
3,233.3900
-6,227.5250
Diluted NI Available to Com Stockholders
3,715.1580
-39.4830
1,788.6890
3,233.3900
-6,227.5250
Basic EPS
0.03
-0.00
0.01
0.03
-0.06
Diluted EPS
0.03
-0.00
0.01
0.03
-0.06
Basic Average Shares
137,913.7980
137,911.8840
135,376.2550
114,845.4250
104,839.3720
Diluted Average Shares
138,167.1170
137,911.8840
141,688.2490
141,683.2090
104,839.3720
Total Operating Income as Reported
--
-2,736.4320
2,610.2130
--
--
Total Expenses
21,384.9720
19,251.2080
16,466.0280
13,756.3650
11,049.5050
Net Income from Continuing & Discontinued Operation
3,715.1580
-39.4830
1,788.6890
3,233.3900
-6,227.5250
Normalized Income
1,868.0070
-3,118.0680
1,788.6890
3,233.3900
-3,964.7650
Interest Income
474.4860
457.7420
82.2700
0.0660
--
Interest Expense
873.5280
839.3780
826.5600
1,603.2710
1,056.1020
Net Interest Income
-399.0420
-381.6360
-744.2900
-1,603.2050
-1,056.1020
EBIT
4,588.6870
799.8950
2,692.4830
4,836.6610
-3,603.1860
EBITDA
5,886.9930
1,957.0640
3,728.8830
5,658.7010
-2,913.0990
Reconciled Cost of Revenue
9,902.8980
8,037.5170
7,075.3430
6,826.3830
5,253.4860
Reconciled Depreciation
1,298.3060
1,157.1690
1,036.4000
822.0400
690.0870
Net Income from Continuing Operation Net Minority Interest
3,715.1580
-39.4830
1,788.6890
3,233.3900
-6,227.5250
Total Unusual Items Excluding Goodwill
3,078.5850
3,078.5850
--
--
-3,078.5850
Total Unusual Items
3,078.5850
3,078.5850
--
--
-3,078.5850
Normalized EBITDA
2,808.4080
-1,121.5210
3,728.8830
5,658.7010
165.4860
Tax Rate for Calcs
0.0004
--
0.0000
--
0.0003
Tax Effect of Unusual Items
1,231.4340
--
--
--
-815.8250
9/30/2020 - 8/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HBP.TO Helix BioPharma Corp.
0.2100
0.00%
 
EPRX.TO Eupraxia Pharmaceuticals Inc.
3.7300
-4.36%
 
XRTX.V XORTX Therapeutics Inc.
4.0700
+12.43%
 
AEZS.TO Aeterna Zentaris Inc.
2.6500
-0.38%
 
APS.TO Aptose Biosciences Inc.
1.7000
+4.94%
 
ONC.TO Oncolytics Biotech Inc.
1.4700
-1.34%
 
BRAX.CN Braxia Scientific Corp.
0.0100
0.00%
 
SVA.TO Sernova Corp.
0.4400
+3.53%
 
TH.TO Theratechnologies Inc.
1.8000
0.00%
 
CRPOF Ceapro Inc.
0.1845
0.00%